Markt oder Branche auswählen:
| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | ||
|---|---|---|---|---|---|
| BIONTECH | 7 | 13 | -0,26 % | ||
| SAGE THERAPEUTICS | 5 | 11 | -3,13 % | ||
| KURA ONCOLOGY | 5 | 2 | 0,00 % | ||
| AMGEN | 4 | 27 | -0,20 % | ||
| 23ANDME | 4 | 8 | 0,00 % | ||
| HUTCHMED | 4 | 7 | 0,00 % | ||
| RECURSION PHARMACEUTICALS | 4 | 3 | 0,00 % | ||
| EXSCIENTIA | 4 | - | -1,74 % | ||
| LEXICON PHARMACEUTICALS | 3 | 4 | +9,38 % | ||
| GRIFOLS | 3 | 4 | -1,83 % |
- 24 h
- 7 Tage
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 09:15 | Bayer, BioNTech, DAX, Evotec, Hensoldt, Nel ASA - 4investors Aktien Top-News | 176 | 4investors | Wo ist am Aktienmarkt etwas los, welche Themen interessieren Anleger derzeit besonders? Vor allem für Trader ist es wichtig zu wissen, wo "die Musik spielt" und welche Themen an der Börse aktuell besonders... ► Artikel lesen | |
| 09:14 | Discover AstraZeneca's Journey Toward Decision-Centric Autonomous Planning at the Gartner Supply Chain Planning Summit in Denver | 73 | ACCESSWIRE | DENVER, CO / ACCESSWIRE / November 21, 2024 / OMP, a leading provider of supply chain planning solutions, returns to the Gartner Supply Chain Planning Summit in Denver as a platinum sponsor. On December... ► Artikel lesen | |
| 06:34 | Bayer, BioNxt Solutions, BioNTech - Patente und Übernahmen für den Marktdurchbruch | 376 | Kapitalerhöhungen.de | Drei Unternehmen aus der Pharmabranche setzen auf unterschiedliche Strategien, um ihre Marktposition zu stärken: Bayer investiert gezielt in den japanischen Herzmedikamenten-Markt und erwirbt für bis... ► Artikel lesen | |
| 02:59 | Kura Oncology Partners With Kyowa Kirin To Develop Ziftomenib For Acute Leukemias; Stock Drops | 2 | RTTNews | ||
| 02:34 | Jazz Pharmaceuticals receives FDA approval for biliary tract cancer treatment | 1 | Reuters | ||
| 02:06 | Cathie Wood's ARK makes major plays in Recursion, Twist Bioscience stock | 10 | Investing.com | ||
| 01:59 | Jazz Pharma Gains FDA Accelerated Approval For Ziihera To Treat HER2-positive Biliary Tract Cancer | 1 | RTTNews | ||
| Mi | Kura Oncology to partner with Kyowa Kirin for blood cancer therapy | 4 | Reuters | ||
| Mi | Acadia Pharmaceuticals Inc - On Nov 18, Co Involuntarily Terminates COO Brendan Teehan | 2 | Reuters | ||
| Mi | Amgen taps Stanford's Howard Chang to take CSO reins from Jay Bradner | 3 | FierceBiotech | ||
| Mi | Kura Oncology, Inc.: Kura Oncology and Kyowa Kirin Announce Global Strategic Collaboration to Develop and Commercialize Ziftomenib in Acute Leukemias | 3 | GlobeNewswire (USA) | ||
| Mi | Kura Oncology and Kyowa Kirin Announce Global Strategic Collaboration to Develop and Commercialize Ziftomenib in Acute Leukemias | 250 | PR Newswire | - Kura to receive a $330 million upfront payment and up to $1.2 billion in total milestone payments, including $420 million in near-term milestone payments and opt-in right for solid tumors... ► Artikel lesen | |
| Mi | Aclaris upgraded to overweight by Cantor on in-licensing deal | 4 | Seeking Alpha | ||
| Mi | Day One Biopharmaceuticals announces R&D leadership change | 1 | Investing.com | ||
| Mi | Myriad Genetics, Inc.: Myriad Genetics Announces Incorporation of its Proprietary HRD platform in Illumina's Updated Comprehensive Gene Panel Assay, TruSight Oncology 500 v2 | 2 | GlobeNewswire (USA) | ||
| Mi | Ultragenyx Pharmaceutical Inc.: Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | 1 | GlobeNewswire (USA) | ||
| Mi | Day One Biopharmaceuticals, Inc.: Day One Announces Retirement of Dr. Samuel Blackman, Co-Founder and Head of Research & Development | 2 | GlobeNewswire (USA) | ||
| Mi | Lexicon Pharmaceuticals appoints Ivan Cheung to board | 2 | Investing.com | ||
| Mi | Nurix gains EMA prime status for leukemia drug candidate | 3 | Investing.com | ||
| Mi | Ironwood Pharmaceuticals SVP verkauft Aktien im Wert von 21.868 US-Dollar | 1 | Investing.com Deutsch |
Seite:
1 2 3 4 5 Weiter >>
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
